150TiP A phase Ib/II trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with anticancer agents in first-line (1L) for advanced solid tumors (Symbiotic-Lung-20)

Category Primary study
ConferenceESMO Open Science for Optimal Cancer Care
Year 2026
This article has no abstract
Epistemonikos ID: 880aa3b2c599c9fa6664a70406b810c2e081687d
First added on: Apr 04, 2026